Moreover, our group has recently described an additional case of a child with high GGT-cholestasis due to a de novo missense pathogenic variant of HNF1B, thus implicating rare mutations in HNF1B in the pathogenetic role in cholestatic liver diseases with increased GGT (Table 2) [65,66]. This evidence concerns the gene HNF1B and Cholestatic liver disease.